We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$22.3B
AUM Growth
+$4.85B
(+28%)
Cap. Flow
+$4.03B
Cap. Flow
% of AUM
18.06%
Top 10 Holdings %
Top 10 Hldgs %
53.96%
Holding
76
New
19
Increased
16
Reduced
22
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$1.7B |
| 2 |
Boeing
BA
|
+$1.01B |
| 3 |
Amazon
AMZN
|
+$915M |
| 4 |
Meta Platforms (Facebook)
META
|
+$902M |
| 5 |
BridgeBio Pharma
BBIO
|
+$726M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$889M |
| 2 |
Marathon Petroleum
MPC
|
+$823M |
| 3 |
Visa
V
|
+$440M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$314M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.43% |
| 2 | Technology | 16.88% |
| 3 | Consumer Discretionary | 15.43% |
| 4 | Communication Services | 13.36% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
51
DELISTED
Blueprint Medicines
BPMC
| $52M | 0.23% |
551,040
-107,621
| -16% | -$8.88M |
|
52
Chewy
CHWY
$9.37B
| $51.5M | 0.23% |
+1,471,890
| New | +$49.7M |
|
53
AnaptysBio
ANAB
$1.65B
| $45.1M | 0.2% |
799,897
-30,263
| -4% | -$2.18M |
|
54
Ingersoll Rand
IR
$33.6B
| $44.4M | 0.2% |
+1,282,486
| New | +$41.4M |
|
55
Assurant
AIZ
$14.2B
| $38.3M | 0.17% |
+360,430
| New | +$35.6M |
|
56
American International
AIG
$40.6B
| $30.1M | 0.14% |
+564,604
| New | +$28.1M |
|
|
EIDX
57
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $27.4M | 0.12% |
882,353
-1,103,848
| -56% | -$29.9M |
|
58
Editas Medicine
EDIT
$435M
| $23M | 0.1% |
931,401
| – | – |
|
|
ATYR
59
aTyr Pharma
ATYR
$51.3M
| $1.18M | 0.01% |
229,283
| – | – |
|
60
Arthur J. Gallagher & Co
AJG
$64.4B
| – | – |
-475,830
| Closed | -$37.2M |
|
61
Allstate
ALL
$68.3B
| – | – |
-1,543,256
| Closed | -$145M |
|
62
Booking.com
BKNG
$159B
| – | – |
-1,491,775
| Closed | -$104M |
|
63
Burlington
BURL
$23.5B
| – | – |
-342,079
| Closed | -$53.6M |
|
64
Walt Disney
DIS
$178B
| – | – |
-2,172,157
| Closed | -$241M |
|
65
Diamondback Energy
FANG
$55.5B
| – | – |
-1,137,514
| Closed | -$115M |
|
|
HES
66
DELISTED
Hess
HES
| – | – |
-1,641,021
| Closed | -$98.8M |
|
67
Jazz Pharmaceuticals
JAZZ
$16.7B
| – | – |
-635,736
| Closed | -$90.9M |
|
68
LyondellBasell Industries
LYB
$20B
| – | – |
-633,235
| Closed | -$53.2M |
|
69
Middleby
MIDD
$5.91B
| – | – |
-622,493
| Closed | -$80.9M |
|
|
70
Marathon Petroleum
MPC
$88.8B
| – | – |
-13,742,884
| Closed | -$823M |
|
71
Progressive
PGR
$124B
| – | – |
-1,105,895
| Closed | -$79.7M |
|
|
72
Thermo Fisher Scientific
TMO
$221B
| – | – |
-1,146,037
| Closed | -$314M |
|
73
Viatris
VTRS
$19B
| – | – |
-3,583,269
| Closed | -$102M |
|
74
Zimmer Biomet
ZBH
$18.6B
| – | – |
-537,110
| Closed | -$66.6M |
|
|
NVRO
75
DELISTED
NEVRO CORP.
NVRO
| – | – |
-112,414
| Closed | -$7.03M |
|
Similar funds
SAM
VIA
Viking Global Investors's Q2 2019 Portfolio in Review
As of Q2 2019, Viking Global Investors held 76 positions worth $22.3B, up 28% from $17.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Viking Global Investors deployed $4.03B of net new capital in Q2 2019, opening 19 new positions and adding to 16 existing holdings. Its largest new stake was Adaptive Biotechnologies: 38,406,607 shares worth $1.86B.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $889M trimmed.
- Viking Global Investors's largest Q2 2019 buy was Adaptive Biotechnologies: 38,406,607 shares worth $1.86B.
- Viking Global Investors added most to Amazon in Q2 2019, an estimated $915M increase.
- Viking Global Investors's biggest Q2 2019 reduction was Alibaba, cutting an estimated $889M.
- Viking Global Investors fully exited Marathon Petroleum in Q2 2019, selling an estimated $823M.
- Viking Global Investors's ten largest holdings make up 54% of its $22.3B portfolio in Q2 2019.
- Viking Global Investors opened 19 new positions and closed 17 in Q2 2019.
- Viking Global Investors's portfolio value rose 28% quarter-over-quarter to $22.3B.
Based on Viking Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.